Per Malmström

4.1k citations

61 papers · 2.6k indexed · h-index 26

Cancer Research top 1%
- Breast Cancer Treatment Studies 36
- Cancer Genomics and Diagnostics 6
Oncology top 2%
- HER2/EGFR in Cancer Research 12
- Cancer Treatment and Pharmacology 10
- Cancer Cells and Metastasis 8
- Cancer survivorship and care 6
Pathology and Forensic Medicine top 5%
- Breast Lesions and Carcinomas 12
Genetics top 5%
- Estrogen and related hormone effects 7
Pulmonary and Respiratory Medicine top 5%

Co-authors: Mårten Fernö Pär‐Ola Bendahl Jorma Isola Sofia K. Gruvberger-Saal Jonas Bergh Åke Borg Lao H. Saal Dorthe Grabau
Cited by: Cancer Research Oncology Pathology and Forensic Medicine
Journals: Journal of Clinical Oncology (10 papers)Breast Cancer Research and Treatment (5 papers)Acta Oncologica (5 papers)
Partner nations: Sweden United States Finland

In The Last Decade

Per Malmström

61 papers receiving 2.6k citations

Peers

Countries citing papers authored by Per Malmström

Since Specialization

Citations

This map shows the geographic impact of Per Malmström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Malmström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Malmström more than expected).

Fields of papers citing papers by Per Malmström

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Malmström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Malmström. The network helps show where Per Malmström may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Per Malmström, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Per Malmström Line = papers co-authored together Per Malmström links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer Journal of Clinical Oncology ·Martin Sjöström,Anthony Fyles,Fei‐Fei Liu,David R. McCready,Wei Shi,Emma Depledge,S. Laura Chang,Felix Y. Feng,Corey Speers,Lori J. Pierce,Erik Holmberg,Mårten Fernö,Per Malmström,Per Karlsson	2023	21
2	Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy The Breast ·Anna Nordenskjöld,Helena Fohlin,Johan Rosell,Nils‐Olof Bengtsson,Tommy� Fornander,Thomas Hatschek,Henrik Lindman,Per Malmström,Lisa Rydén,Arne Wallgren,Olle Stål,Bo Nordenskjöld	2023	2
3	Breast cancer hypoxia in relation to prognosis and benefit from radiotherapy after breast-conserving surgery in a large, randomised trial with long-term follow-up British Journal of Cancer ·Zhao Ze-li,Martin Sjöström,Erik Holmberg,Per Karlsson,Fredrika Killander,L.M. Fredrik Leeb-Lundberg,Per Malmström,Emma Niméus,Mårten Fernö,Annika Jögi	2022	34
4	High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer npj Breast Cancer ·Мария Юрьевна Кузьмина,Pär‐Ola Bendahl,Mårten Fernö,Per Malmström,Signe Borgquist,Siker Kimbung	2021	11
5	No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial International Journal of Radiation OncologyBiologyPhysics ·Fredrika Killander,Elinore Wieslander,Per Karlsson,Erik Holmberg,Dan Lundstedt,Lars Holmberg,Linda L. Werner,Sasha Koul,K. Turetschek,Elisabeth Kjellén,Per Nilsson,Per Malmström	2020	16
6	Comprehensive Transcriptomic Profiling Identifies Breast Cancer Patients Who May Be Spared Adjuvant Systemic Therapy Clinical Cancer Research ·Martin Sjöström,S. Laura Chang,Nick Fishbane,Elai Davicioni,Linda Hartman,Erik Holmberg,Felix Y. Feng,Corey Speers,Lori J. Pierce,Per Malmström,Mårten Fernö,Per Karlsson	2019	12
7	Long-term safety and survival outcomes from the Scandinavian Breast Group 2004-1 randomized phase II trial of tailored dose-dense adjuvant chemotherapy for early breast cancer Breast Cancer Research and Treatment ·Alexios Matikas,Sara Margolin,Mats Hellström,Hemming Johansson,Nils‐Olof Bengtsson,IVAN GASKELL,Per Edlund,Per Karlsson,Elisabet Lidbrink,Barbro Linderholm,Henrik Lindman,Per Malmström,Kenneth Villman,Theodoros Foukakis,Jonas Bergh	2017	7
8	The role of histological grade in discrimination between Luminal A-like and Luminal B-like subtypes in a series of premenopausal breast cancer patients Lund University Publications (Lund University) ·Anna Ehinger,Pär‐Ola Bendahl,C.W. Elston,Per Malmström,Dorthe Grabau,Mårten Fernö	2014	2
9	Increased cardio and cerebrovascular mortality in breast cancer patients treated with postmastectomy radiotherapy – 25 year follow-up of a randomised trial from the South Sweden Breast Cancer Group European Journal of Cancer ·Fredrika Killander,Harald Anderson,Elisabeth Kjellén,Per Malmström	2014	22
10	G Protein–Coupled Estrogen Receptor Is Apoptotic and Correlates with Increased Distant Disease-Free Survival of Estrogen Receptor–Positive Breast Cancer Patients Clinical Cancer Research ·Stefan Broselid,Benxu Cheng,Martin Sjöström,Kristina Lövgren,Anastasiya Alexeevna Semiletova,Mattias Belting,Karin Jirström,Per Malmström,Björn Olde,Pär‐Ola Bendahl,Linda Hartman,Mårten Fernö,L.M. Fredrik Leeb-Lundberg	2013	35
11	The Prognostic Value of Mitotic Activity Index (MAI), Phosphohistone H3 (PPH3), Cyclin B1, Cyclin A, and Ki67, Alone and in Combinations, in Node-Negative Premenopausal Breast Cancer PLoS ONE ·Marie Klintman,Carina Strand,Cecilia Ahlin,Zhang Zeqia,Marie-Louise Fjällskog,Dorthe Grabau,Einar Gudlaugsson,Emiel A. M. Janssen,Kristina Lövgren,Ivar Skaland,Pär‐Ola Bendahl,Per Malmström,Jan P. A. Baak,Mårten Fernö	2013	24
12	Claudin‐2 is an independent negative prognostic factor in breast cancer and specifically predicts early liver recurrences Molecular Oncology ·Siker Kimbung,Anikó Kovács,Pär‐Ola Bendahl,Per Malmström,Mårten Fernö,Thomas Hatschek,Ingrid Hedenfalk	2013	47
13	Estrogen Receptor β Expression Is Associated with Tamoxifen Response in ERα-Negative Breast Carcinoma Clinical Cancer Research ·Sofia K. Gruvberger-Saal,Pär‐Ola Bendahl,Lao H. Saal,Mervi Laakso,Cecilia Hegardt,P. Edén,Carsten Peterson,Per Malmström,Jorma Isola,Åke Borg,Mårten Fernö	2007	154
14	Radiotherapy and tamoxifen after mastectomy in postmenopausal women – 20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I European Journal of Cancer ·Fredrika Killander,Harald Anderson,Stefan Rydén,Henrik Møller,Knut Aspegren,Jeanette Ceberg,Juguo Wang,Per Malmström	2007	19
15	Physical Performance, Toxicity, and Quality of Life as Assessed by the Physician and the Patient Acta Oncologica ·Minna‐Liisa Luoma,Liisa Hakamies‐Blomqvist,Johanna Sjöström,田中信悟,A Płużańska,Per Malmström,Alida Kouajip-Mabou,Ragnar Hultborn,Madeleine Chávez,Ingvil Mjaaland,Vahur Valvere,Erik Wist,Ranjana Mukhopadhyaya,Johan Ahlgren,Carl Blomqvist	2002	13
16	Tailored fluorouracil, epirubicin, and cyclophosphamide compared with marrow-supported high-dose chemotherapy as adjuvant treatment for high-risk breast cancer: a randomised trial The Lancet ·Jonas Bergh,Tom Wiklund,Björn Erikstein,Elisabet Lidbrink,Henrik Lindman,Per Malmström,Pirkko Kellokumpu‐Lehtinen,Nils‐Olof Bengtsson,Gustaf Söderlund,Gun Anker,Erik Wist,S. Ottosson,Eeva Salminen,Per Ljungman,Harald Holte,Jonas Nilsson,Carl Blomqvist,Nils Wilking	2000	217
17	Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian Breast Group European Journal of Cancer ·Liisa Hakamies‐Blomqvist,Minna‐Liisa Luoma,J Sjöström,A Płużańska,Marie Sjödin,Henning T. Mouridsen,Bjørn Østenstad,Ingvil Mjaaland,Sara Mambrilla,Jonas Bergh,Per Malmström,Carl Blomqvist	2000	38
18	Psychological profile related to malignant tumours of different histopathology Psycho-Oncology ·Åsa Lilja,Gudmund J. W. Smith,Per Malmström,Leif G. Salford,Ingrid Idvall	1998	8
19	Reoperation for malignant astrocytomas: Personal experience and a review of the literature British Journal of Neurosurgery ·Lars-Göran Strömblad,Harald Anderson,Per Malmström,Leif G. Salford	1993	18
20	A randomized study of chemotherapy with procarbazine, vincristine, and lomustine with and without radiation therapy for astrocytoma grades 3 and/or 4 Cancer ·Magnhild Sandberg‐Wollheim,K Hougaard,Per Malmström,Lars-Göran Strömblad,Leif G. Salford,Harald Anderson,S Borgström,Arne Brun,S. Cronqvist	1991	97

About Per Malmström

Per Malmström is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Genetics, having authored 61 papers that have together received 2.6k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (36 papers), HER2/EGFR in Cancer Research (12 papers), Breast Lesions and Carcinomas (12 papers), Cancer Treatment and Pharmacology (10 papers), Cancer Cells and Metastasis (8 papers), Estrogen and related hormone effects (7 papers), Cancer Genomics and Diagnostics (6 papers) and Cancer survivorship and care (6 papers). The work is most often cited by research in Cancer Research (1.1k citations), Oncology (1.3k citations), Pathology and Forensic Medicine (306 citations), Genetics (176 citations) and Pulmonary and Respiratory Medicine (515 citations). Per Malmström has collaborated with scholars based in Sweden, United States and Finland. Frequent co-authors include Mårten Fernö, Pär‐Ola Bendahl, Jorma Isola, Sofia K. Gruvberger-Saal, Jonas Bergh, Åke Borg, Lao H. Saal, Dorthe Grabau, Martin Sjöström and Carl Blomqvist. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Acta Oncologica, European Journal of Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact